25 XP   0   0   10

Connect Biopharma Holdings Ltd
Buy, Hold or Sell?

Let's analyse Connect Biopharma Holdings Ltd together

PenkeI guess you are interested in Connect Biopharma Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Connect Biopharma Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Connect Biopharma Holdings Ltd

I send you an email if I find something interesting about Connect Biopharma Holdings Ltd.

Quick analysis of Connect Biopharma Holdings Ltd (30 sec.)










What can you expect buying and holding a share of Connect Biopharma Holdings Ltd? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
$2.75
Expected worth in 1 year
$-3.66
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$-6.41
Return On Investment
-461.1%

For what price can you sell your share?

Current Price per Share
$1.39
Expected price per share
$1.05 - $2.84
How sure are you?
50%

1. Valuation of Connect Biopharma Holdings Ltd (5 min.)




Live pricePrice per Share (EOD)

$1.39

Intrinsic Value Per Share

$-28.25 - $-33.78

Total Value Per Share

$-25.50 - $-31.03

2. Growth of Connect Biopharma Holdings Ltd (5 min.)




Is Connect Biopharma Holdings Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$151.4m$239.7m-$88.2m-58.3%

How much money is Connect Biopharma Holdings Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$110m-$180.4m$70.3m64.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Connect Biopharma Holdings Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#300 / 1009

Most Revenue
#979 / 1009

Most Profit
#973 / 1009

Most Efficient
#414 / 1009

What can you expect buying and holding a share of Connect Biopharma Holdings Ltd? (5 min.)

Welcome investor! Connect Biopharma Holdings Ltd's management wants to use your money to grow the business. In return you get a share of Connect Biopharma Holdings Ltd.

What can you expect buying and holding a share of Connect Biopharma Holdings Ltd?

First you should know what it really means to hold a share of Connect Biopharma Holdings Ltd. And how you can make/lose money.

Speculation

The Price per Share of Connect Biopharma Holdings Ltd is $1.39. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Connect Biopharma Holdings Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Connect Biopharma Holdings Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.75. Based on the TTM, the Book Value Change Per Share is $-1.60 per quarter. Based on the YOY, the Book Value Change Per Share is $6.92 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Connect Biopharma Holdings Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.00-143.8%-2.00-143.8%-3.28-235.8%-1.91-137.5%-1.91-137.5%
Usd Book Value Change Per Share-1.60-115.3%-1.60-115.3%6.92498.1%0.6949.5%0.6949.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.60-115.3%-1.60-115.3%6.92498.1%0.6949.5%0.6949.5%
Usd Price Per Share0.87-0.87-5.15-1.50-1.50-
Price to Earnings Ratio-0.43--0.43--1.57--0.50--0.50-
Price-to-Total Gains Ratio-0.54--0.54-0.74-0.10-0.10-
Price to Book Ratio0.32-0.32-1.18-0.37-0.37-
Price-to-Total Gains Ratio-0.54--0.54-0.74-0.10-0.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.39
Number of shares719
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.600.69
Usd Total Gains Per Share-1.600.69
Gains per Quarter (719 shares)-1,152.04494.52
Gains per Year (719 shares)-4,608.181,978.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4608-4618019781968
20-9216-9226139553946
30-13825-13834159335924
40-18433-18442279117902
50-23041-23050298889880
60-27649-2765831186611858
70-32257-3226631384413836
80-36865-3687441582115814
90-41474-4148241779917792
100-46082-4609041977719770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.03.025.0%1.00.03.025.0%1.00.03.025.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%

Fundamentals of Connect Biopharma Holdings Ltd

About Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. The company's product candidates also comprise CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis; and CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with skin inflammation. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-11 04:38:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Connect Biopharma Holdings Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Connect Biopharma Holdings Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Connect Biopharma Holdings Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Connect Biopharma Holdings Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Connect Biopharma Holdings Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Connect Biopharma Holdings Ltd to the Biotechnology industry mean.
  • -65.8% Return on Assets means that Connect Biopharma Holdings Ltd generated $-0.66 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Connect Biopharma Holdings Ltd:

  • The MRQ is -65.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -65.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-65.8%TTM-65.8%0.0%
TTM-65.8%YOY-70.4%+4.7%
TTM-65.8%5Y-63.3%-2.5%
5Y-63.3%10Y-63.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-65.8%-13.3%-52.5%
TTM-65.8%-12.8%-53.0%
YOY-70.4%-11.7%-58.7%
5Y-63.3%-13.9%-49.4%
10Y-63.3%-15.7%-47.6%
1.1.3. Return on Equity

Shows how efficient Connect Biopharma Holdings Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Connect Biopharma Holdings Ltd to the Biotechnology industry mean.
  • 0.0% Return on Equity means Connect Biopharma Holdings Ltd generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Connect Biopharma Holdings Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-75.3%+75.3%
TTM-5Y-18.8%+18.8%
5Y-18.8%10Y-18.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-75.3%-15.1%-60.2%
5Y-18.8%-19.3%+0.5%
10Y-18.8%-20.2%+1.4%

1.2. Operating Efficiency of Connect Biopharma Holdings Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Connect Biopharma Holdings Ltd is operating .

  • Measures how much profit Connect Biopharma Holdings Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Connect Biopharma Holdings Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Connect Biopharma Holdings Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Connect Biopharma Holdings Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Connect Biopharma Holdings Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of Connect Biopharma Holdings Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Connect Biopharma Holdings Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.97 means the company has $9.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Connect Biopharma Holdings Ltd:

  • The MRQ is 9.970. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.970. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.970TTM9.9700.000
TTM9.970YOY15.298-5.328
TTM9.9705Y16.581-6.611
5Y16.58110Y16.5810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.9703.890+6.080
TTM9.9704.173+5.797
YOY15.2985.344+9.954
5Y16.5816.126+10.455
10Y16.5816.448+10.133
1.3.2. Quick Ratio

Measures if Connect Biopharma Holdings Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Connect Biopharma Holdings Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 15.07 means the company can pay off $15.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Connect Biopharma Holdings Ltd:

  • The MRQ is 15.072. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 15.072. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ15.072TTM15.0720.000
TTM15.072YOY15.298-0.226
TTM15.0725Y17.811-2.739
5Y17.81110Y17.8110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.0723.514+11.558
TTM15.0723.998+11.074
YOY15.2985.380+9.918
5Y17.8116.105+11.706
10Y17.8116.404+11.407

1.4. Solvency of Connect Biopharma Holdings Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Connect Biopharma Holdings Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Connect Biopharma Holdings Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Connect Biopharma Holdings Ltd assets are financed with 9.5% credit (debt) and the remaining percentage (100% - 9.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Connect Biopharma Holdings Ltd:

  • The MRQ is 0.095. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.095. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.095TTM0.0950.000
TTM0.095YOY0.065+0.030
TTM0.0955Y0.976-0.881
5Y0.97610Y0.9760.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0950.339-0.244
TTM0.0950.336-0.241
YOY0.0650.271-0.206
5Y0.9760.366+0.610
10Y0.9760.389+0.587
1.4.2. Debt to Equity Ratio

Measures if Connect Biopharma Holdings Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Connect Biopharma Holdings Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Connect Biopharma Holdings Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.069-0.069
TTM-5Y0.017-0.017
5Y0.01710Y0.0170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM-0.402-0.402
YOY0.0690.335-0.266
5Y0.0170.426-0.409
10Y0.0170.461-0.444

2. Market Valuation of Connect Biopharma Holdings Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Connect Biopharma Holdings Ltd generates.

  • Above 15 is considered overpriced but always compare Connect Biopharma Holdings Ltd to the Biotechnology industry mean.
  • A PE ratio of -0.43 means the investor is paying $-0.43 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Connect Biopharma Holdings Ltd:

  • The EOD is -0.695. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.434. Based on the earnings, the company is expensive. -2
  • The TTM is -0.434. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.695MRQ-0.434-0.261
MRQ-0.434TTM-0.4340.000
TTM-0.434YOY-1.572+1.137
TTM-0.4345Y-0.501+0.067
5Y-0.50110Y-0.5010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.695-2.264+1.569
MRQ-0.434-2.629+2.195
TTM-0.434-2.680+2.246
YOY-1.572-4.145+2.573
5Y-0.501-6.257+5.756
10Y-0.501-6.254+5.753
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Connect Biopharma Holdings Ltd:

  • The EOD is -0.782. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.488. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.488. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.782MRQ-0.488-0.294
MRQ-0.488TTM-0.4880.000
TTM-0.488YOY-3.466+2.978
TTM-0.4885Y-0.989+0.501
5Y-0.98910Y-0.9890.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.782-2.973+2.191
MRQ-0.488-3.333+2.845
TTM-0.488-3.553+3.065
YOY-3.466-5.605+2.139
5Y-0.989-8.376+7.387
10Y-0.989-8.865+7.876
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Connect Biopharma Holdings Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.32 means the investor is paying $0.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Connect Biopharma Holdings Ltd:

  • The EOD is 0.505. Based on the equity, the company is cheap. +2
  • The MRQ is 0.315. Based on the equity, the company is cheap. +2
  • The TTM is 0.315. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.505MRQ0.315+0.190
MRQ0.315TTM0.3150.000
TTM0.315YOY1.183-0.868
TTM0.3155Y0.375-0.059
5Y0.37510Y0.3750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5051.896-1.391
MRQ0.3152.115-1.800
TTM0.3152.093-1.778
YOY1.1832.884-1.701
5Y0.3753.542-3.167
10Y0.3753.916-3.541
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Connect Biopharma Holdings Ltd.

3.1. Institutions holding Connect Biopharma Holdings Ltd

Institutions are holding 44.032% of the shares of Connect Biopharma Holdings Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RA Capital Management, LLC5.56160.05653062871-3928132-56.1884
2023-12-31BML Capital Management LLC3.74321.8425206143820614380
2023-12-31BlackRock Inc1.888601040067-85195-7.5711
2023-12-31UBS O'Connor LLC1.0190.0476561191-42709-7.0722
2023-12-31Renaissance Technologies Corp0.54110.0005298000201000207.2165
2023-12-31Geode Capital Management, LLC0.0508027961892946.9157
2023-12-31Rhumbline Advisers0.0301652000
2023-12-31XTX Topco Ltd0.02820.00415506155060
2023-12-31TWO SIGMA SECURITIES, LLC0.02230.000112307123070
2023-12-31Two Sigma Investments LLC0.0207011405-5814-33.765
2023-12-31Keudell/Morrison Wealth Management0.02030.004411200112000
2023-12-31Royal Bank of Canada0.000804494490
2023-12-31JPMorgan Chase & Co0.00020121-23411-99.4858
2023-12-31Qube Research & Technologies0.000104600
2023-12-31FMR Inc0023-1-4.1667
2023-09-30Susquehanna International Group, LLP000-10470-100
2023-09-30Ikarian Capital, LLC000-219501-100
2023-12-31Morgan Stanley - Brokerage Accounts000-1-100
2023-12-31Kynam Capital Management, LP000-535005-100
2023-12-31Adage Capital Partners Gp LLC000-650000-100
Total 12.92691.95567119105-3189410-44.8%

3.2. Funds holding Connect Biopharma Holdings Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29BlackRock Health Sciences Term Trust1.88860.0608104006700
2024-02-29Fidelity Nasdaq Composite Index0.05080.00022796100
2024-02-29LUX IM Global Medtech HX0.00450.0014250000
2024-03-28SPDR® Portfolio Emerging Markets ETF0.0002011100
Total 1.94410.0624107063900.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Connect Biopharma Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.602-1.6020%6.923-123%0.688-333%0.688-333%
Book Value Per Share--2.7512.7510%4.353-37%0.949+190%0.949+190%
Current Ratio--9.9709.9700%15.298-35%16.581-40%16.581-40%
Debt To Asset Ratio--0.0950.0950%0.065+47%0.976-90%0.976-90%
Debt To Equity Ratio----0%0.069-100%0.017-100%0.017-100%
Dividend Per Share----0%0.001-100%0.000-100%0.000-100%
Eps---1.999-1.9990%-3.277+64%-1.912-4%-1.912-4%
Free Cash Flow Per Share---1.778-1.7780%-1.486-16%-0.987-44%-0.987-44%
Free Cash Flow To Equity Per Share---1.779-1.7790%1.815-198%0.414-530%0.414-530%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---33.776--------
Intrinsic Value_10Y_min---28.250--------
Intrinsic Value_1Y_max---1.706--------
Intrinsic Value_1Y_min---1.658--------
Intrinsic Value_3Y_max---6.406--------
Intrinsic Value_3Y_min---6.027--------
Intrinsic Value_5Y_max---12.648--------
Intrinsic Value_5Y_min---11.509--------
Market Cap76549524.000+38%47791134.48047791134.4800%283618740.000-83%82852468.620-42%82852468.620-42%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.505+38%0.3150.3150%1.183-73%0.375-16%0.375-16%
Pe Ratio-0.695-60%-0.434-0.4340%-1.572+262%-0.501+15%-0.501+15%
Price Per Share1.390+38%0.8680.8680%5.150-83%1.504-42%1.504-42%
Price To Free Cash Flow Ratio-0.782-60%-0.488-0.4880%-3.466+610%-0.989+103%-0.989+103%
Price To Total Gains Ratio-0.868-60%-0.542-0.5420%0.744-173%0.101-636%0.101-636%
Quick Ratio--15.07215.0720%15.298-1%17.811-15%17.811-15%
Return On Assets---0.658-0.6580%-0.704+7%-0.633-4%-0.633-4%
Return On Equity----0%-0.7530%-0.1880%-0.1880%
Total Gains Per Share---1.602-1.6020%6.924-123%0.688-333%0.688-333%
Usd Book Value--151477747.000151477747.0000%239718261.100-37%52114417.225+191%52114417.225+191%
Usd Book Value Change Per Share---1.602-1.6020%6.923-123%0.688-333%0.688-333%
Usd Book Value Per Share--2.7512.7510%4.353-37%0.949+190%0.949+190%
Usd Dividend Per Share----0%0.001-100%0.000-100%0.000-100%
Usd Eps---1.999-1.9990%-3.277+64%-1.912-4%-1.912-4%
Usd Free Cash Flow---97910828.500-97910828.5000%-81818035.500-16%-54384919.325-44%-54384919.325-44%
Usd Free Cash Flow Per Share---1.778-1.7780%-1.486-16%-0.987-44%-0.987-44%
Usd Free Cash Flow To Equity Per Share---1.779-1.7790%1.815-198%0.414-530%0.414-530%
Usd Market Cap76549524.000+38%47791134.48047791134.4800%283618740.000-83%82852468.620-42%82852468.620-42%
Usd Price Per Share1.390+38%0.8680.8680%5.150-83%1.504-42%1.504-42%
Usd Profit---110073295.500-110073295.5000%-180472394.400+64%-105466244.975-4%-105466244.975-4%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---1.602-1.6020%6.924-123%0.688-333%0.688-333%
 EOD+5 -3MRQTTM+0 -0YOY+7 -235Y+7 -2310Y+7 -23

4.2. Fundamental Score

Let's check the fundamental score of Connect Biopharma Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.695
Price to Book Ratio (EOD)Between0-10.505
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than115.072
Current Ratio (MRQ)Greater than19.970
Debt to Asset Ratio (MRQ)Less than10.095
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.658
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Connect Biopharma Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.498
Ma 20Greater thanMa 501.748
Ma 50Greater thanMa 1001.436
Ma 100Greater thanMa 2001.250
OpenGreater thanClose1.340
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,211,930
Total Liabilities115,060
Total Stockholder Equity-3,175,220
 As reported
Total Liabilities 115,060
Total Stockholder Equity+ -3,175,220
Total Assets = 1,211,930

Assets

Total Assets1,211,930
Total Current Assets1,084,937
Long-term Assets126,993
Total Current Assets
Cash And Cash Equivalents 550,274
Short-term Investments 511,250
Net Receivables 1,615
Other Current Assets 23
Total Current Assets  (as reported)1,084,937
Total Current Assets  (calculated)1,063,162
+/- 21,775
Long-term Assets
Property Plant Equipment 37,454
Long Term Investments 65,744
Intangible Assets 22,041
Long-term Assets Other 237
Long-term Assets  (as reported)126,993
Long-term Assets  (calculated)125,476
+/- 1,517

Liabilities & Shareholders' Equity

Total Current Liabilities108,817
Long-term Liabilities6,243
Total Stockholder Equity-3,175,220
Total Current Liabilities
Short-term Debt 1,294
Accounts payable 83,138
Other Current Liabilities 24,385
Total Current Liabilities  (as reported)108,817
Total Current Liabilities  (calculated)108,817
+/-0
Long-term Liabilities
Capital Lease Obligations 2,998
Long-term Liabilities  (as reported)6,243
Long-term Liabilities  (calculated)2,998
+/- 3,245
Total Stockholder Equity
Common Stock66
Retained Earnings -3,175,220
Accumulated Other Comprehensive Income 71,120
Other Stockholders Equity -71,186
Total Stockholder Equity (as reported)-3,175,220
Total Stockholder Equity (calculated)-3,175,220
+/-0
Other
Capital Stock66
Cash and Short Term Investments 1,127,268
Common Stock Shares Outstanding 54,969
Liabilities and Stockholders Equity -3,060,160
Net Debt -547,276
Net Invested Capital 1,096,870
Net Working Capital 976,120
Property Plant and Equipment Gross 51,524
Short Long Term Debt Total 2,998



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
0
372,588
1,084,869
1,855,659
1,211,930
1,211,9301,855,6591,084,869372,5880
   > Total Current Assets 
445,725
362,812
1,056,799
1,754,135
1,084,937
1,084,9371,754,1351,056,799362,812445,725
       Cash And Cash Equivalents 
0
308,972
1,010,076
1,706,880
550,274
550,2741,706,8801,010,076308,9720
       Short-term Investments 
0
30,632
13,068
4
511,250
511,250413,06830,6320
       Net Receivables 
370
1,211
1,731
47,255
1,615
1,61547,2551,7311,211370
       Other Current Assets 
0
49
43
43
23
234343490
   > Long-term Assets 
0
9,776
28,070
101,524
126,993
126,993101,52428,0709,7760
       Property Plant Equipment 
3,140
3,422
17,468
82,158
37,454
37,45482,15817,4683,4223,140
       Long Term Investments 
0
0
0
0
65,744
65,7440000
       Intangible Assets 
0
0
342
22,547
22,041
22,04122,54734200
       Long-term Assets Other 
0
6,354
10,260
18,806
237
23718,80610,2606,3540
> Total Liabilities 
0
670,875
2,109,814
119,828
115,060
115,060119,8282,109,814670,8750
   > Total Current Liabilities 
6,328
27,397
37,997
114,665
108,817
108,817114,66537,99727,3976,328
       Short-term Debt 
0
412
604
630
1,294
1,2946306044120
       Accounts payable 
3,437
22,788
24,638
81,195
83,138
83,13881,19524,63822,7883,437
       Other Current Liabilities 
45
4,197
12,755
32,840
24,385
24,38532,84012,7554,19745
   > Long-term Liabilities 
0
643,478
2,071,817
5,163
6,243
6,2435,1632,071,817643,4780
       Other Liabilities 
0
0
0
5,000
0
05,000000
> Total Stockholder Equity
0
-298,287
-1,024,945
1,735,831
-3,175,220
-3,175,2201,735,831-1,024,945-298,2870
   Common Stock
21
21
24
66
66
6666242121
   Retained Earnings Total Equity00000
   Accumulated Other Comprehensive Income 
0
-48,725
-1,693
-41,244
71,120
71,120-41,244-1,693-48,7250
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
-41,696
42,533
48,065
4,155,174
-71,186
-71,1864,155,17448,06542,533-41,696



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-785,217
Operating Income-805,589-785,217
 
Operating Expense (+$)
Research Development652,211
Selling General Administrative139,444
Selling And Marketing Expenses0
Operating Expense785,217791,655
 
Net Interest Income (+$)
Interest Income10,715
Interest Expense-144
Other Finance Cost-0
Net Interest Income10,571
 
Pretax Income (+$)
Operating Income-805,589
Net Interest Income10,571
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-795,018-816,160
EBIT - interestExpense = -805,733
-795,018
-796,911
Interest Expense144
Earnings Before Interest and Taxes (EBIT)-805,589-794,874
Earnings Before Interest and Taxes (EBITDA)-762,069
 
After tax Income (+$)
Income Before Tax-795,018
Tax Provision-2,037
Net Income From Continuing Ops-797,055-797,055
Net Income-797,055
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses785,217
Total Other Income/Expenses Net10,571-10,571
 

Technical Analysis of Connect Biopharma Holdings Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Connect Biopharma Holdings Ltd. The general trend of Connect Biopharma Holdings Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Connect Biopharma Holdings Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Connect Biopharma Holdings Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.66 < 2.84.

The bearish price targets are: 1.32 > 1.1 > 1.05.

Tweet this
Connect Biopharma Holdings Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Connect Biopharma Holdings Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Connect Biopharma Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Connect Biopharma Holdings Ltd. The current macd is 0.00554231.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Connect Biopharma Holdings Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Connect Biopharma Holdings Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Connect Biopharma Holdings Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Connect Biopharma Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartConnect Biopharma Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Connect Biopharma Holdings Ltd. The current adx is 31.71.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Connect Biopharma Holdings Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Connect Biopharma Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Connect Biopharma Holdings Ltd. The current sar is 1.98317791.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Connect Biopharma Holdings Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Connect Biopharma Holdings Ltd. The current rsi is 43.50. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Connect Biopharma Holdings Ltd Daily Relative Strength Index (RSI) ChartConnect Biopharma Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Connect Biopharma Holdings Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Connect Biopharma Holdings Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Connect Biopharma Holdings Ltd Daily Stochastic Oscillator ChartConnect Biopharma Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Connect Biopharma Holdings Ltd. The current cci is -116.79662335.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Connect Biopharma Holdings Ltd Daily Commodity Channel Index (CCI) ChartConnect Biopharma Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Connect Biopharma Holdings Ltd. The current cmo is -24.42267207.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Connect Biopharma Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartConnect Biopharma Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Connect Biopharma Holdings Ltd. The current willr is -89.11665676.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Connect Biopharma Holdings Ltd Daily Williams %R ChartConnect Biopharma Holdings Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Connect Biopharma Holdings Ltd.

Connect Biopharma Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Connect Biopharma Holdings Ltd. The current atr is 0.24092582.

Connect Biopharma Holdings Ltd Daily Average True Range (ATR) ChartConnect Biopharma Holdings Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Connect Biopharma Holdings Ltd. The current obv is 30,802,160.

Connect Biopharma Holdings Ltd Daily On-Balance Volume (OBV) ChartConnect Biopharma Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Connect Biopharma Holdings Ltd. The current mfi is 22.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Connect Biopharma Holdings Ltd Daily Money Flow Index (MFI) ChartConnect Biopharma Holdings Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Connect Biopharma Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Connect Biopharma Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Connect Biopharma Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.498
Ma 20Greater thanMa 501.748
Ma 50Greater thanMa 1001.436
Ma 100Greater thanMa 2001.250
OpenGreater thanClose1.340
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Connect Biopharma Holdings Ltd with someone you think should read this too:
  • Are you bullish or bearish on Connect Biopharma Holdings Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Connect Biopharma Holdings Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Connect Biopharma Holdings Ltd

I send you an email if I find something interesting about Connect Biopharma Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Connect Biopharma Holdings Ltd.

Receive notifications about Connect Biopharma Holdings Ltd in your mailbox!